Edwards Lifesciences Corporation
US ˙ NYSE ˙ US28176E1082

SecurityEW / Edwards Lifesciences Corporation
InstitutionWELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2
Latest Disclosed Ownership461 shares
Latest Disclosed Value $ 36,054
WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 reports 4.95% decrease in ownership of EW / Edwards Lifesciences Corporation

On August 26, 2025 - WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 filed a NPORT-P form disclosing ownership of 461 shares of Edwards Lifesciences Corporation (US:EW) valued at $36,055 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 485 shares of Edwards Lifesciences Corporation. This represents a change in shares of -4.95% during the quarter. The current value of the position is $39,628 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Edwards Lifesciences EC US28176E1082 461 -24 -4.95 36 2.86 0.0531
2025-05-27 2025-03-31 NP Edwards Lifesciences EC US28176E1082 485 -15 -3.00 35 -5.41 0.0530
2025-02-26 2024-12-31 NP Edwards Lifesciences EC US28176E1082 500 -44 -8.09 37 5.71 0.0530
2024-11-25 2024-09-30 NP Edwards Lifesciences EC US28176E1082 544 -15 -2.68 36 -31.37 0.0495
2024-08-26 2024-06-30 NP Edwards Lifesciences EC US28176E1082 559 -17 -2.95 52 -7.27 0.0740
2024-05-28 2024-03-31 NP Edwards Lifesciences EC US28176E1082 576 -31 -5.11 55 19.57 0.0789
2024-02-28 2023-12-31 NP Edwards Lifesciences EC US28176E1082 607 -16 -2.57 46 6.98 0.0694
2023-11-22 2023-09-30 NP Edwards Lifesciences EC US28176E1082 623 -70 -10.10 43 -33.85 0.0694
2023-08-28 2023-06-30 NP Edwards Lifesciences EC US28176E1082 693 -10 -1.42 65 12.07 0.0986
2023-05-25 2023-03-31 NP Edwards Lifesciences EC US28176E1082 703 -14 -1.95 58 9.43 0.0902
2023-02-24 2022-12-31 NP Edwards Lifesciences EC US28176E1082 717 -16 -2.18 53 -11.67 0.0855
2022-11-29 2022-09-30 NP EDWARDS LIFESCIENCES CORP USD1.0 EC US28176E1082 733 -20 -2.66 61 -15.49 0.0988
2022-08-29 2022-06-30 NP EDWARDS LIFESCIENCES CORP USD1.0 EC US28176E1082 753 -18 -2.33 72 -21.11 0.1090
2022-05-31 2022-03-31 NP EDWARDS LIFESCIENCES CORP USD1.0 EC US28176E1082 771 -22 -2.77 91 -11.76 0.1188
2022-02-28 2021-12-31 NP EDWARDS LIFESCIENCES CORP USD1.0 EC US28176E1082 793 -27 -3.29 103 10.87 0.1236
2021-11-24 2021-09-30 NP EDWARDS LIFESCIENCES CORP USD1.0 EC US28176E1082 820 -34 -3.98 93 4.55 0.1154
2021-08-27 2021-06-30 NP EDWARDS LIFESCIENCES CORP USD1.0 EC US28176E1082 854 -50 -5.53 88 17.33 0.1079
2021-06-01 2021-03-31 NP EDWARDS LIFESCIENCES CORP USD1.0 EC US28176E1082 904 -49 -5.14 76 -12.79 0.0953
2021-03-01 2020-12-31 NP EDWARDS LIFESCIENCES CORP USD1.0 EC US28176E1082 953 -57 -5.64 87 7.50 0.1103
2020-11-25 2020-09-30 NP EDWARDS LIFESCIENCES CORP USD1.0 EC US28176E1082 1,010 -37 -3.53 81 11.11 0.1082
2020-08-28 2020-06-30 NP EDWARDS LIFESCIENCES CORP USD1.0 EC US28176E1082 1,047 712 212.54 72 14.29 0.1016
2020-05-28 2020-03-31 NP EDWARDS LIFESCIENCES CORP USD1.0 EC US28176E1082 335 -7 -2.05 63 -20.25 0.0989
2020-02-28 2019-12-31 NP EDWARDS LIFESCIENCES CORP USD1.0 EC 28176E108 342 -22 -6.04 80 -1.25 0.1104
2019-11-26 2019-09-30 NP EDWARDS LIFESCIENCES CORP USD1.0 EC US28176E1082 364 364 80 0.1109
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.